Page last updated: 2024-09-04

moxifloxacin and Acute Bacterial Prostatitis

moxifloxacin has been researched along with Acute Bacterial Prostatitis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charlier, C; Lécuyer, H; Lortholary, O; Pilmis, B	1
Magri, V; Marras, E; Perletti, G; Restelli, A	1
Kees, F; Lunz, JC; Naber, KG; Wagenlehner, FM; Wieland, W	1
Bschleipfer, T; Wagenlehner, FM; Weidner, W	1
Groeneveld, JH; Kuijper, EJ; van Nieuwkoop, C; Visser, LG	1

Trials

2 trial(s) available for moxifloxacin and Acute Bacterial Prostatitis

Article	Year
Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Biological Availability; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prostate; Prostatic Hyperplasia; Prostatitis; Quinolines; Transurethral Resection of Prostate	2006
[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin]. Der Urologe. Ausg. A, 2007, Volume: 46, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Biomarkers, Tumor; Biopsy; Double-Blind Method; Fluoroquinolones; Humans; Male; Moxifloxacin; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatitis; Quinolines	2007

Article

Year

Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.

Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5

Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Biological Availability; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prostate; Prostatic Hyperplasia; Prostatitis; Quinolines; Transurethral Resection of Prostate

2006

[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].

Der Urologe. Ausg. A, 2007, Volume: 46, Issue:9

Topics: Anti-Infective Agents; Aza Compounds; Biomarkers, Tumor; Biopsy; Double-Blind Method; Fluoroquinolones; Humans; Male; Moxifloxacin; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatitis; Quinolines

2007

Other Studies

3 other study(ies) available for moxifloxacin and Acute Bacterial Prostatitis

Article	Year
Enterococcus faecalis-related prostatitis successfully treated with moxifloxacin. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Anti-Bacterial Agents; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis	2015
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. Anaerobe, 2010, Volume: 16, Issue:3 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Moxifloxacin; Peptostreptococcus; Prostatitis; Quinolines; Treatment Outcome	2010
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin. The Journal of infection, 2008, Volume: 56, Issue:2 Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Chronic Disease; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Prostatitis; Quinolines; Recurrence; Treatment Outcome	2008